SARCULATOR vs EMSOS 2026
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
SARCULATOR
This medical tool provides physicians with predictive models for retroperitoneal and extremity sarcoma patients. It estimates overall survival and disease-free survival, serving as an informative resource to enhance physician predictive capabilities.
- Predictive models for sarcoma patients
- Estimates 5-year overall survival
- Estimates 5-year disease-free survival
- Estimates 10-year overall survival
- Estimates cumulative incidence of distant metastasis
- Informative tool for physicians
Read full descriptionHide full description
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - ESTS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
EMSOS 2026
Read full descriptionHide full description
Official app for the participants of the 2026 meeting of European Musculo-Skeletal Oncology Society Use this app to: - Browse information about the event, such as speakers and agenda - Give feedback by rating sessions, abstracts and speakers - Receive important notifications from the organisation - Interact with other participants by private messages and sharing photos on the event feed
Screenshots
Verdict
SARCULATOR and EMSOS 2026 are too close to call on the numbers: across 5 compared parameters — price, ads, in-app purchases and device support among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | SARCULATOR | EMSOS 2026 |
|---|---|---|
| Price | Free | Free |
| Rating | 4.3 (3 ratings) — better | — |
| Number of ratings | 3 — better | — |
| Update frequency | Every 6 months | — |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.0 — better | 15.4 |
| Further details — not scored | ||
| Size | 29 MB | 24 MB |
| Age rating | 12+ | 17+ |
| Developer | DIGITAL FOREST SRL | Meeting Point |
In-app purchases
SARCULATOR
No in-app purchases
EMSOS 2026
No in-app purchases
